Purpose: This study aimed to analyze the concepts of experiential avoidance, anxiety sensitivity and behavioral inhibition system through healthy volunteers and patients diagnosed with anxiety disorder. It was planned to analyze and evaluate the correlation among the levels of experiential avoidance, anxiety sensitivity and behavioral inhibition system in various anxiety groups.
Method: Within the scope of this study, clinical interviews were carried out with patients who sought treatment at the Psychiatry Department of the Hospital of Balıkesir University Medical Faculty.
Objective: Postpartum depression (PPD) has negative effects on the mothers who experience it. The aims of the study described herein were to determine the prevalence of PPD and to determine the correlations between PPD and perceived social support, quality of life, and the risk factors for PPD.
Methods: Data were collected using a questionnaire prepared by the researchers and that included the Edinburgh Postnatal Depression Scale, the Beck Depression Scale, the Quality of Life scale, the Multidimensional Scale of Perceived Social Support, and questions regarding the sociodemographic characteristics and PPD risk factors of the mother.
Introduction: Neuropeptide S (NPS) is a novel neuropeptide reported to be involved in fear-and stress-related conditions and their corresponding neuroendocrine processes. The aim of this study was to compare the plasma NPS levels in patients suffering from generalized anxiety disorder (GAD) and those of healthy controls.
Methods: A total of 40 subjects diagnosed with GAD and 40 healthy controls were recruited in the study.
Purpose: Neuropeptide-S (NPS) is a novel 20-amino acid peptide, mainly expressed in the central nervous system and endocrine tissues. NPS has been linked to anxiety and fear-related behaviors. The association of NPS with depression in a human population has not been previously examined.
View Article and Find Full Text PDFBackground: The aim of this study is to evaluate vitamin D levels and rs2228570 (FokI) polymorphism of vitamin D in patients with established diagnosis of major depressive disorder in order to investigate the impact of vitamin D levels and genetic polymorphisms on etiology and/or severity of the disease.
Subjects And Methods: The study included 86 patients who were diagnosed with major depressive disorder in Hospital of Balıkesir University Faculty of Medicine, Department of Psychiatry, and 89 healthy volunteers with similar age, sex, education level and BMI. Psychiatric diagnosis was established by using Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I).